This service is a structured assessment designed for startups to evaluate the viability and strategic positioning of their Life Sciences innovations. Delivered over 1 to 3 months, the service is targeted at startups seeking to improve their investment readiness and market positionings before commercialisation.
The service consists of three key phases:
1. Diagnostic Phase: In-house business and financial experts conduct an initial data review to understand the technological value proposition, development stage, and strategic context.
2. Evaluation Phase: Includes market potential analysis, stakeholder consultations, and benchmarking against competitors and regulatory scenarios. Experts assess risks and opportunities, identify value inflection points, and align the business model with commercial expectations.
3. Reporting Phase: A final report is produced summarising key findings, investment readiness score, and recommendations for further development or partnering. The goal is to deliver a clear and objective appraisal that supports strategic decision-making, facilitates investor dialogue, and prepares the company for future funding or co-development pathways. The service is provided online by in-house consultants with experience in life sciences innovation, investment, and market access.
€25,000 - €50,000.
The expected timeframe for service completion is approximately 1 to 3 months.
Due Diligence
Are you in doubt if this is the right service for you, or do you want to get more information about the service? Get in touch with the EIC Partner providing this service through this query form!
Is this the service you are looking for? If so, you can apply to the service through EIC ACCESS+! Eligible applicants can also get co-funding through the EIC ACCESS+ initiative. Find out more on the project webiste.
Receive up to €60,000 in grants, covering up to 50% of the costs, to access specialised services from the EIC Service Catalogue. Learn more on the EIC ACCESS+ website.